top stories

'It's the bi­ol­o­gy, stu­pid': Re­la­tion and GSK team up on fi­bro­sis, os­teoarthri­tis

1 hour ago
Startups
Deals
AI

Trump el­e­vates dis­proven link be­tween vac­cines and autism, say­ing ‘some­thing is go­ing on’

4 hours ago
Pharma

Bel­har­ra Ther­a­peu­tics sticks with lead pro­grams, trims work­force by 40%

5 hours ago
People
Startups

Supreme Court de­clines to take PhRMA-Arkansas 340B case over ex­pan­sion

4 hours ago
Pharma
Law

Latest

Most read

Po­lice ar­rest per­son of in­ter­est in con­nec­tion with killing of Unit­ed­Health­care CEO

5 hours ago
People
Law

Agios' stock drops af­ter dis­clos­ing new liv­er-re­lat­ed safe­ty warn­ing in fil­ing to FDA

6 hours ago
Pharma
FDA+

Ex­clu­sive: Vi­jay Pande hands a16z biotech lead­er­ship to Vi­nee­ta Agar­wala, moves to AI role

6 hours ago
People
Startups

GSK re­ports Blenrep over­all sur­vival da­ta in mul­ti­ple myelo­ma as it plots mar­ket reen­try

6 hours ago
R&D
Pharma

ICER finds Ver­tex's non-opi­oid pain treat­ment could bring cost sav­ings at a low­er price

8 hours ago
R&D

Ab­b­Vie, Gen­mab tout Ep­kin­ly com­bos in ear­li­er lines of non-Hodgkin lym­phoma

8 hours ago
R&D
Pharma
see latest stream
People

ADC sci­en­tist who paved the way for Dai­ichi’s En­her­tu dies

13 hours ago

Na­tion­al Re­silience to cut 105 em­ploy­ees at Flori­da site as new CEO takes over

3 days ago

Af­ter Unit­ed­Health­care CEO killing, health­care in­dus­try faces a new se­cu­ri­ty re­al­i­ty

4 days ago
Financing

Di­men­sion nabs $500M sec­ond fund for 'still con­trary' in­ter­sec­tion of bio and ma­chine learn­ing

12 hours ago

Dutch biotech nabs €85M to po­si­tion in­flam­ma­to­ry an­ti­body for a phar­ma buy­er

18 hours ago

Nu­vig rais­es $161M as it pre­pares for Phase 2 study in hot au­toim­mune field

4 days ago
Startups

Some re­search shows pa­tients don’t stick with GLP-1s for long. Ama­zon Phar­ma­cy and Ro say they're chang­ing that

9 hours ago

BioAge Labs scraps Phase 2 obe­si­ty tri­al just months af­ter IPO

3 days ago

GSK's third new pact of the week fo­cus­es on Alzheimer's with start­up Mu­na Ther­a­peu­tics

4 days ago
Deals

Eu­ro­pean Com­mis­sion green­lights $16.5B No­vo-Catal­ent ac­qui­si­tion 

3 days ago

Eli­av Barr de­fends Mer­ck­'s LaNo­va deal, but cau­tions VEGF bis­pecifics have yet to de­liv­er ma­ture da­ta

4 days ago

Gen­mab li­cens­es sec­ond mon­o­clon­al an­ti­body from Scan­cell

4 days ago

In FocusSee all

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

5 days ago
R&D
Discovery

Law­mak­ers are pok­ing holes in phar­ma's fa­vorite new way to mar­ket med­i­cines

3 weeks ago
Pharma
Health Tech

A rare neu­ro­log­i­cal dis­ease is Sage’s last, best hope af­ter fail­ures in de­pres­sion

3 weeks ago
R&D
Pharma

Yorvipath’s ap­proval show­cas­es bio­phar­ma’s in­ter­est in rare en­docrine dis­or­der

4 weeks ago
Startups
R&D

Endpoints Standouts

How the world's biggest phar­ma and biotech com­pa­nies paid their typ­i­cal work­er in 2023

5 months ago
People
Pharma

In biotech's un­even re­cov­ery, 50 star­tups raised megarounds in first half of 2024

5 months ago
Financing
Startups

Bio­phar­ma lead­ers chart­ing a path for the in­dus­try's LGBTQ+ com­mu­ni­ty

5 months ago
People
Special

Pe­ter Marks sin­gle-hand­ed­ly ap­proved Sarep­ta’s gene ther­a­py — what does that mean for every­one else?

5 months ago
Pharma
Cell/Gene Tx

Peer review See all

Dec
6

Mark Alles’ ADC bet TORL poach­es J&J med­ical ex­ec; Sam­sung Bioepis makes his­toric CEO ap­point­ment

Nov
22

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Nov
15

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

Nov
8

Leg­end names a pres­i­dent of Carvyk­ti; No­vo Nordisk's top North Amer­i­ca ex­ec is step­ping down

Nov
1

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

Pharma channel feed

3 days ago

In­sur­ance ex­ec­u­tive killing puts spot­light on se­cu­ri­ty mea­sures at JP Mor­gan meet­ing

The usu­al en­hanced se­cu­ri­ty mea­sures are ex­pect­ed to be in place in San Fran­cis­co next month when the health­care in­dus­try de­scends on the city for the JP Mor­gan health­care con­fer­ence. But ...

READ MORE

Af­ter switch­ing reg­u­la­to­ry plans, As­traZeneca and Dai­ichi re­port pooled ADC da­ta in mu­tant lung can­cer

3 days ago
R&D

Merus re­ceives FDA ac­cel­er­at­ed ap­proval to treat NRG1+ can­cers

4 days ago
FDA+
latest in Pharma

Lil­ly con­tin­ues to ex­pand its em­pire of GLP-1 fac­to­ries with new $3B build­out

4 days ago
Manufacturing

USP­TO with­draws pro­posed patent rule crit­i­cized by phar­ma in­dus­try

4 days ago
FDA+

FDA spells out new ex­pe­dit­ed with­draw­al pro­ce­dures for ac­cel­er­at­ed ap­provals

4 days ago
FDA+

Imfinzi snags an­oth­er FDA nod to treat lung can­cer, this time for lim­it­ed-stage SCLC

4 days ago
FDA+

GSK ex­tends Shin­grix pact in Chi­na but for less mon­ey, adds RSV vac­cine deal

4 days ago
Deals
see latest stories

Marketing channel feed

3 days ago

No­var­tis bol­sters Fab­hal­ta da­ta in com­pe­ti­tion with As­traZeneca

No­var­tis’ Fab­hal­ta im­proved he­mo­glo­bin lev­els in pa­tients with a rare blood dis­or­der who switched from an­ti-C5 ther­a­pies, bol­ster­ing the drug’s case against As­traZeneca’s com­pet­ing ...

READ MORE

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

3 weeks ago
Pharma

FDA says Merz's so­cial me­dia pro­mo­tion with Nate Berkus is 'mis­lead­ing'

4 weeks ago
Pharma
latest in Marketing

Val­ne­va and Pfiz­er eye 2027 launch for part­nered Ly­me dis­ease vac­cine

Last month
Pharma

UK watch­dog crit­i­cizes Mod­er­na for Covid-19 tri­al's use of What­sApp to dan­gle pay­ments to chil­dren

2 months ago
Pharma

FDA crit­i­cizes Ab­b­Vie's 'mis­lead­ing' ad with Ser­e­na Williams

2 months ago
Pharma
FDA+

Up­dat­ed: Madri­gal fi­nal­ly re­veals first wave of sales for MASH drug Rezd­if­fra

4 months ago
Pharma

RSV mar­ket pres­sure leads to slow­er launch for Mod­er­na's vac­cine

4 months ago
Pharma
see latest stories

FDA+ channel feed

4 days ago

Biose­cure com­pro­mise could add ex­ec­u­tive re­view process for named com­pa­nies, sources say

Law­mak­ers are con­sid­er­ing a com­pro­mise to leg­is­la­tion tar­get­ing Chi­nese life sci­ence com­pa­nies that would add an ex­ec­u­tive branch re­view in­stead of au­to­mat­i­cal­ly bar­ring bio­phar­ma com­pa­nies ...

READ MORE

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

5 days ago
R&D
Pharma

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

5 days ago
Pharma
latest in FDA+

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

5 days ago
Pharma

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

6 days ago
Pharma

Eli Lil­ly, Pfiz­er stress in­de­pen­dence of tele­health part­ners in re­sponse to sen­a­tors

6 days ago
Pharma

Ap­plied Ther­a­peu­tics gets FDA warn­ing let­ter over study of re­ject­ed rare dis­ease drug

6 days ago

FDA de­fends in­creased use of guid­ance in new re­port to Con­gress

Last week
see latest stories

Manufacturing channel feed

Yesterday

Biose­cure bill is left out of end-of-year de­fense pack­age, deal­ing blow to chances

Leg­is­la­tion tar­get­ing pop­u­lar Chi­nese biotech con­trac­tors like WuXi AppTec was­n't in­clud­ed in must-pass de­fense leg­is­la­tion that rep­re­sent­ed its best chances as this ses­sion of Con­gress ...

READ MORE

UK’s lo­cal vac­cine pro­duc­tion stymied by bud­get cuts, gov­ern­ment com­mit­tee says

3 days ago

Am­gen deep­ens roots in North Car­oli­na with lat­est $1B fac­to­ry build 

4 days ago
latest in Manufacturing

Na­tion­al Re­silience's new CEO; Mod­er­na opens Aus­tralian man­u­fac­tur­ing site

4 days ago

No­vo Nordisk bud­gets $409M for new qual­i­ty con­trol lab in Den­mark 

4 days ago

No­vavax sells Czech fa­cil­i­ty to No­vo Nordisk for $200M to cut costs

5 days ago
Deals

Sanofi ear­marks €1B for new in­sulin pro­duc­tion fac­to­ry in Bei­jing   

Last week
China

Agenus launch­es bi­o­log­ics man­u­fac­tur­ing busi­ness to gen­er­ate cash

Last week
Financing
see latest stories
A service from the Financial Times